Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.3            MARKET SCOPE
1.3.1             MARKETS COVERED.. 16
1.3.2             YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY USED FOR THE STUDY
1.5            MAJOR MARKET STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH DATA
2.1.1             SECONDARY DATA
2.1.1.1           MAJOR SECONDARY SOURCES REFERRED
2.1.2             PRIMARY DATA
2.2            MARKET ESTIMATION METHODOLOGY
2.2.1             PROCEDURE-BASED MARKET ESTIMATION
2.2.2             REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.3             PRIMARY RESEARCH VALIDATION
2.3            DATA TRIANGULATION
2.4            RESEARCH ASSUMPTIONS
2.5            RESEARCH LIMITATIONS

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            LIVE CELL ENCAPSULATION MARKET OVERVIEW
4.2            EUROPE: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE
4.3            GLOBAL LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE
4.4            LIVE CELL ENCAPSULATION MARKET, BY APPLICATION
4.5            LIVE CELL ENCAPSULATION MARKET, BY COUNTRY

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1             DRIVERS
5.2.1.1           INCREASING INCIDENCE OF TARGET DISEASES
5.2.1.2           FOCUS ON NOVEL DRUG DELIVERY SYSTEMS FOR DISEASE TREATMENT
5.2.1.3           TECHNOLOGY ADVANCEMENTS
5.2.1.4           INCREASING PUBLIC-PRIVATE INVESTMENTS TO SUPPORT NOVEL PRODUCT DEVELOPMENT
5.2.1.5           RISING PUBLIC AWARENESS RELATED TO THE CLINICAL ROLE OF ENCAPSULATED CELLS IN DISEASE MANAGEMENT
5.2.2             RESTRAINTS
5.2.2.1           HIGH PRODUCT MANUFACTURING COSTS
5.2.2.2           LIMITED MARKET AVAILABILITY OF HIGH-QUALITY RAW MATERIALS
5.2.3             OPPORTUNITIES
5.2.3.1           RISING RESEARCH ACTIVITY
5.2.4             CHALLENGES
5.2.4.1           ADOPTION OF ALTERNATIVE THERAPIES

6.... LIVE CELL ENCAPSULATION MARKET, BY MANUFACTURING TECHNIQUES

6.1            INTRODUCTION
6.2            SIMPLE DRIPPING
6.2.1             GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR SIMPLE DRIPPING TECHNIQUE, BY APPLICATION
6.3            ELECTROSTATIC DRIPPING
6.3.1             GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR ELECTROSTATIC DRIPPING TECHNIQUE, BY APPLICATION
6.4            COAXIAL AIRFLOW
6.4.1             GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR COAXIAL AIRFLOW TECHNIQUE, BY APPLICATION
6.5            LIQUID-JET BREAK-UP
6.5.1             GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR LIQUID JET BREAK UP TECHNIQUE, BY APPLICATION.. 48
6.6            VIBRATING-JET TECHNIQUE
6.6.1             GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR VIBRATING JET TECHNIQUE, BY APPLICATION
6.7            JET CUTTING
6.7.1             GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR JET CUTTING TECHNIQUE, BY APPLICATION
6.8            ROTATING DISK ATOMIZATION
6.8.1             GLOBAL LIVE CELL ENCAPSULATION MARKET SPLIT FOR ROTATING DISK ATOMIZATION TECHNIQUE, BY APPLICATION

7.... LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE

7.1            INTRODUCTION
7.2            ALGINATE
7.2.1             ALGINATE IS THE MOST WIDELY ADOPTED MATERIAL FOR THE ENCAPSULATION OF LIVING CELLS
7.3            HEMA-MMA
7.3.1             HEMA-MMA-BASED PRODUCTS ARE USED MAINLY FOR LIVER TRANSPLANTATION PROCEDURES AND DIABETES MANAGEMENT

7.4            CHITOSAN
7.4.1             INADEQUATE AVAILABILITY OF NATURAL CHITOSAN SOURCES IS EXPECTED TO HAMPER MARKET GROWTH
7.5            SILICEOUS ENCAPSULATES
7.5.1             PROCEDURAL BENEFITS OFFERED BY SILICEOUS ENCAPSULATES SUCH AS EFFECTIVE PROCESS CONTROL & HIGH PROCESS ADJUSTABILITY TO DRIVE MARKET GROWTH
7.6            CELLULOSE SULFATE
7.6.1             TECHNO-COMMERCIAL BENEFITS SUCH AS HIGH MECHANICAL STABILITY & ADJUSTABILITY TO DRIVE MARKET GROWTH
7.7            PAN-PVC
7.7.1             PAN-PVC POLYMERS HAVE MECHANICAL STABILITY, PERMEABILITY, AND HIGH BIOCOMPATIBILITY
7.8            OTHER POLYMERS

8.... LIVE CELL ENCAPSULATION MARKET, BY APPLICATION

8.1            INTRODUCTION
8.2            DRUG DELIVERY
8.2.1             DRUG DELIVERY FORMS THE LARGEST APPLICATION SEGMENT OF THE LIVE CELL ENCAPSULATION MARKET
8.3            REGENERATIVE MEDICINE
8.3.1             CLINICAL RISK OF CLOGGING IN THE HEPATIC VASCULAR SYSTEM IS EXPECTED TO HAMPER THE ADOPTION OF CELL ENCAPSULATION FOR REGENERATIVE MEDICINE
8.4            CELL TRANSPLANTATION
8.4.1             INCREASING INCIDENCE OF TARGET DISEASES & TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF CELL TRANSPLANTATION TO SUPPORT MARKET GROWTH
8.5            PROBIOTICS
8.5.1             PROBIOTICS APPLICATIONS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
8.6            RESEARCH
8.6.1             GROWING AWARENESS ABOUT THE RESEARCH APPLICATIONS OF CELL ENCAPSULATION TECHNIQUES AND THE INCREASING AVAILABILITY OF PUBLIC-PRIVATE FUNDING, INVESTMENTS, & GRANTS TO DRIVE MARKET GROWTH

9.... LIVE CELL ENCAPSULATION MARKET, BY REGION

9.1            INTRODUCTION
9.2            NORTH AMERICA
9.2.1             US
9.2.1.1           US ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL LIVE CELL ENCAPSULATION MARKET IN 2018; THIS TREND TO CONTINUE DURING THE FORECAST PERIOD
9.2.2             CANADA
9.2.2.1           GROWTH IN THE LIVE CELL ENCAPSULATION MARKET IN CANADA IS DRIVEN BY THE GROWING RESEARCH ACTIVITIES RELATED TO CELL ENCAPSULATION
9.3            EUROPE
9.3.1             GERMANY
9.3.1.1           GERMANY TO WITNESS THE HIGHEST GROWTH IN THE EUROPEAN LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
9.3.2             UK
9.3.2.1           GROWTH IN THIS MARKET IS DRIVEN BY THE INCREASING NUMBER OF AWARENESS ACTIVITIES RELATED TO THE TECHNOLOGICAL ADVANCEMENTS AND EFFICIENCY OF CELL ENCAPSULATION TECHNIQUES
9.3.3             FRANCE
9.3.3.1           INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
9.3.4             REST OF EUROPE
9.4            ASIA PACIFIC
9.4.1             JAPAN
9.4.1.1           JAPAN TO REGISTER THE HIGHEST GROWTH IN THE ASIA PACIFIC LIVE CELL ENCAPSULATION MARKET
9.4.2             CHINA
9.4.2.1           SUPPORTIVE GOVERNMENT REGULATIONS FOR THE EXPANSION AND MODERNIZATION OF HEALTHCARE FACILITIES ARE DRIVING MARKET GROWTH
9.4.3             INDIA
9.4.3.1           INCREASING PREVALENCE OF TARGET CHRONIC DISEASES TO SUPPORT MARKET GROWTH
9.4.4             REST OF ASIA PACIFIC
9.5            LATIN AMERICA
9.6            MIDDLE EAST & AFRICA

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          GLOBAL MARKET SHARE ANALYSIS (2017)
10.3          COMPETITIVE SCENARIO (2015 TO 2019)
10.4          COMPETITIVE LEADERSHIP MAPPING
10.4.1           VENDOR INCLUSION CRITERIA
10.4.1.1         VISIONARY LEADERS
10.4.1.2         INNOVATORS
10.4.1.3         DYNAMIC DIFFERENTIATORS
10.4.1.4         EMERGING COMPANIES

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
11.1          INTRODUCTION
11.2          BALCHEM CORPORATION
11.3          BIOTIME, INC.
11.4          BLACKTRACE GROUP
11.5          BÜCHI LABORTECHNIK AG
11.6          ENCAPSYS, LLC
11.7          EVONIK INDUSTRIES
11.8          LIVING CELL TECHNOLOGIES
11.9          LYCORED
11.10        MERCK KGAA
11.11        MIKROCAPS
11.12        NEUROTECH HOLDINGS, LLC.
11.13        REED PACIFIC PTY LIMITED
11.14        SERNOVA CORPORATION
11.15        SIGILON THERAPEUTICS
11.16        VIACYTE, INC.
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12.. APPENDIX

LIST OF TABLES

TABLE 1              LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2017–2024 (USD MILLION)
TABLE 2              LIVE CELL ENCAPSULATION MARKET FOR SIMPLE DRIPPING, BY REGION,
2017–2024 (USD MILLION)
TABLE 3              LIVE CELL ENCAPSULATION MARKET FOR SIMPLE DRIPPING, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 4              LIVE CELL ENCAPSULATION MARKET FOR ELECTROSTATIC DRIPPING, BY REGION, 2017–2024 (USD MILLION)
TABLE 5              LIVE CELL ENCAPSULATION MARKET FOR ELECTROSTATIC DRIPPING,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 6              LIVE CELL ENCAPSULATION MARKET FOR COAXIAL AIRFLOW, BY REGION,
2017–2024 (USD MILLION)
TABLE 7              LIVE CELL ENCAPSULATION MARKET FOR COAXIAL AIRFLOW, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 8              LIVE CELL ENCAPSULATION MARKET FOR LIQUID-JET BREAK-UP, BY REGION, 2017–2024 (USD MILLION)
TABLE 9              LIVE CELL ENCAPSULATION MARKET FOR LIQUID-JET BREAK-UP, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 10            LIVE CELL ENCAPSULATION MARKET FOR VIBRATING-JET TECHNIQUE, BY REGION, 2017–2024 (USD MILLION)
TABLE 11            LIVE CELL ENCAPSULATION MARKET FOR VIBRATING-JET TECHNIQUE,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 12            LIVE CELL ENCAPSULATION MARKET FOR JET CUTTING, BY REGION,
2017–2024 (USD MILLION)
TABLE 13            LIVE CELL ENCAPSULATION MARKET FOR JET CUTTING, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 14            LIVE CELL ENCAPSULATION MARKET FOR ROTATING DISK ATOMIZATION,
BY REGION, 2017–2024 (USD MILLION)
TABLE 15            LIVE CELL ENCAPSULATION MARKET FOR ROTATING DISK ATOMIZATION,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 16            LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE,
2017–2024 (USD MILLION)
TABLE 17            LIVE CELL ENCAPSULATION MARKET FOR ALGINATE, BY REGION,
2017–2024 (USD MILLION)
TABLE 18            LIVE CELL ENCAPSULATION MARKET FOR HEMA-MMA, BY REGION,
2017–2024 (USD MILLION)
TABLE 19            LIVE CELL ENCAPSULATION MARKET FOR CHITOSAN, BY REGION,
2017–2024 (USD MILLION)
TABLE 20            LIVE CELL ENCAPSULATION MARKET FOR SILICEOUS ENCAPSULATES, BY REGION, 2017–2024 (USD MILLION)
TABLE 21            LIVE CELL ENCAPSULATION MARKET FOR CELLULOSE SULFATE, BY REGION, 2017–2024 (USD MILLION)
TABLE 22            LIVE CELL ENCAPSULATION MARKET FOR PAN-PVC, BY REGION,
2017–2024 (USD MILLION)
TABLE 23            LIVE CELL ENCAPSULATION MARKET FOR OTHER POLYMERS, BY REGION,
2017–2024 (USD MILLION)
TABLE 24            LIVE CELL ENCAPSULATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 25            LIVE CELL ENCAPSULATION MARKET FOR DRUG DELIVERY, BY REGION,
2017–2024 (USD MILLION)
TABLE 26            LIVE CELL ENCAPSULATION MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2017–2024 (USD MILLION)
TABLE 27            LIVE CELL ENCAPSULATION MARKET FOR CELL TRANSPLANTATION,
BY REGION, 2017–2024 (USD MILLION)
TABLE 28            LIVE CELL ENCAPSULATION MARKET FOR PROBIOTICS, BY REGION,
2017–2024 (USD MILLION)
TABLE 29            LIVE CELL ENCAPSULATION MARKET FOR RESEARCH, BY REGION,
2017–2024 (USD MILLION)
TABLE 30            LIVE CELL ENCAPSULATION MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 31            LIVE CELL ENCAPSULATION MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 32            NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 33            NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET FOR SIMPLE DRIPPING,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34            NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 35            NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE,
2017–2024 (USD MILLION)
TABLE 36            NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 37            US: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 38            CANADA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 39            EUROPE: LIVE CELL ENCAPSULATION MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 40            EUROPE: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 41            EUROPE: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE,
2017–2024 (USD MILLION)
TABLE 42            EUROPE: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 43            GERMANY: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 44            UK: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 45            FRANCE: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 46            ROE: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 47            ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 48            ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 49            ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE,
2017–2024 (USD MILLION)
TABLE 50            ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 51            JAPAN: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 52            CHINA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 53            INDIA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 54            ROAPAC: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 55            LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 56            LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE,
2017–2024 (USD MILLION)
TABLE 57            LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 58            MEA: LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE,
2017–2024 (USD MILLION)
TABLE 59            MEA: LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE,
2017–2024 (USD MILLION)
TABLE 60            MEA: LIVE CELL ENCAPSULATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 61            KEY PRODUCT LAUNCHES
TABLE 62            KEY EXPANSIONS
TABLE 63            KEY ACQUISITIONS
TABLE 64            KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

FIGURE 1            RESEARCH DESIGN
FIGURE 2            BREAKDOWN OF PRIMARIES: LIVE CELL ENCAPSULATION MARKET
FIGURE 3            RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4            MARKET SIZE ESTIMATION: LIVE CELL ENCAPSULATION MARKET
FIGURE 5            DATA TRIANGULATION METHODOLOGY
FIGURE 6            LIVE CELL ENCAPSULATION MARKET, BY TECHNIQUE, 2018 VS. 2024
FIGURE 7            LIVE CELL ENCAPSULATION MARKET, BY POLYMER TYPE,
2018 VS. 2024 (USD MILLION)
FIGURE 8            LIVE CELL ENCAPSULATION MARKET SHARE, BY APPLICATION, 2018 VS. 2024
FIGURE 9            GEOGRAPHIC SNAPSHOT: LIVE CELL ENCAPSULATION MARKET
FIGURE 10          RISING RESEARCH ACTIVITY AND FOCUS ON NOVEL DRUG DELIVERY SYSTEMS FOR DISEASE TREATMENT WILL DRIVE DEMAND FOR LIVE CELL ENCAPSULATION
FIGURE 11          ALGINATES TO DOMINATE THE EUROPEAN LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
FIGURE 12          SIMPLE DRIPPING SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
FIGURE 13          NORTH AMERICA WILL DOMINATE THE LIVE CELL ENCAPSULATION APPLICATION MARKET IN 2018
FIGURE 14          US AND GERMANY TO BE THE FASTEST-GROWING MARKETS FOR LIVE CELL ENCAPSULATION   35
FIGURE 15          LIVE CELL ENCAPSULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16          SIMPLE DRIPPING SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
FIGURE 17          ALGINATE SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
FIGURE 18          DRUG DELIVERY SEGMENT TO DOMINATE THE LIVE CELL ENCAPSULATION MARKET DURING THE FORECAST PERIOD
FIGURE 19          NORTH AMERICA: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
FIGURE 20          EUROPE: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
FIGURE 21          ASIA PACIFIC: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
FIGURE 22          LATIN AMERICA: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
FIGURE 23          MEA: LIVE CELL ENCAPSULATION MARKET SNAPSHOT
FIGURE 24          KEY DEVELOPMENTS IN THE LIVE CELL ENCAPSULATION MARKET FROM
2014 TO 2018
FIGURE 25          BIOTIME, INC HELD THE LEADING POSITION IN THE LIVE CELL ENCAPSULATION MARKET IN 2017
FIGURE 26          COMPETITIVE LEADERSHIP MAPPING (2017)
FIGURE 27          BALCHEM CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 28          BIOTIME, INC.: COMPANY SNAPSHOT (2017)
FIGURE 29          EVONIK INDUSTRIES: COMPANY SNAPSHOT (2017)
FIGURE 30          LIVING CELL TECHNOLOGIES: COMPANY SNAPSHOT (2017)
FIGURE 31          MERCK KGAA: COMPANY SNAPSHOT (2017)

当レポートのプレスリリースは発行されておりません。